Context Therapeutics Analyst Ratings
Context Therapeutics Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/11/2023 | 344.44% | Maxim Group | → $4 | Initiates Coverage On | → Buy |
| 06/06/2023 | — | HC Wainwright & Co. | Reiterates | → Neutral | |
| 03/23/2023 | — | HC Wainwright & Co. | Downgrades | Buy → Neutral | |
| 02/07/2023 | 344.44% | HC Wainwright & Co. | → $4 | Reiterates | → Buy |
| 02/02/2022 | 566.67% | HC Wainwright & Co. | → $6 | Initiates Coverage On | → Buy |
| 01/24/2022 | 1011.11% | ThinkEquity | → $10 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 09/11/2023 | 344.44% | Maxim 集團 | → 4 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 06/06/2023 | — | HC Wainwright & Co. | 重申 | → 中立 | |
| 03/23/2023 | — | HC Wainwright & Co. | 降級 | 買入 → 中性 | |
| 02/07/2023 | 344.44% | HC Wainwright & Co. | → 4 美元 | 重申 | → 購買 |
| 02/02/2022 | 566.67% | HC Wainwright & Co. | → 6 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 2022 年 1 月 24 日 | 1011.11% | ThinkEqu | → 10 美元 | 啓動覆蓋範圍開啓 | → 購買 |
What is the target price for Context Therapeutics (CNTX)?
Context Therapeutics（CNTX）的目標價格是多少？
The latest price target for Context Therapeutics (NASDAQ: CNTX) was reported by Maxim Group on September 11, 2023. The analyst firm set a price target for $4.00 expecting CNTX to rise to within 12 months (a possible 344.44% upside). 4 analyst firms have reported ratings in the last year.
Maxim集團於2023年9月11日公佈了Context Therapeutics（納斯達克股票代碼：CNTX）的最新目標股價。該分析公司將目標股價定爲4.00美元，預計CNTX將在12個月內升至該水平（可能上漲344.44％）。去年有4家分析公司公佈了評級。
What is the most recent analyst rating for Context Therapeutics (CNTX)?
Context Therapeutics（CNTX）的最新分析師評級是多少？
The latest analyst rating for Context Therapeutics (NASDAQ: CNTX) was provided by Maxim Group, and Context Therapeutics initiated their buy rating.
Context Therapeutics（納斯達克股票代碼：CNTX）的最新分析師評級由Maxim集團提供，Context Therapeutics啓動了買入評級。
When is the next analyst rating going to be posted or updated for Context Therapeutics (CNTX)?
Context Therapeutics（CNTX）的下一份分析師評級何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Context Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Context Therapeutics was filed on September 11, 2023 so you should expect the next rating to be made available sometime around September 11, 2024.
分析師在進行了廣泛的研究後得出了股票評級，包括閱讀公開財務報表、與Context Therapeutics的高管和客戶交談以及聽取業績電話會議。大多數分析師每三個月進行一次評級，因此每家公司每年應獲得4個評級。Context Therapeutics的最後一次評級是在2023年9月11日提交的，因此你應該預計下一個評級將在2024年9月11日左右公佈。
Is the Analyst Rating Context Therapeutics (CNTX) correct?
分析師評級 Context Therapeutics (CNTX) 是否正確？
While ratings are subjective and will change, the latest Context Therapeutics (CNTX) rating was a initiated with a price target of $0.00 to $4.00. The current price Context Therapeutics (CNTX) is trading at is $0.90, which is within the analyst's predicted range.
雖然評級是主觀的，並且會發生變化，但最新的Context Therapeutics（CNTX）評級最初的目標價爲0.00美元至4.00美元。Context Therapeutics（CNTX）的當前交易價格爲0.90美元，在分析師的預測區間內。
譯文內容由第三人軟體翻譯。